You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human T-lymphotropic Virus 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human T-Lymphotropic Virus Type 1 Associated Myelopathy Trial in Belém (Inspiratory muscle trainning, Exercise)

Recruiting
  • Human T-Lymphotropic Virus Type 1 Associated Myelopathy
  • Inspiratory muscle trainning
  • Exercise
  • Belém, Pará, Brazil
    Universidade do Estado do Pará
Apr 30, 2021

Evaluation of Patients With HAM/TSP

Recruiting
  • HTLV-I Infection
  • Tropical Spastic Paraparesis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Survival of Adult T-cell Leukemia / Lymphoma and Patients

    Recruiting
    • Lymphoproliferation Induced by HTLV-1
    • +2 more
      • Paris, France
        Hôpital Necker Enfants Malades
      Sep 26, 2022

      HTLV-I Infection Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Raltegravir)

      Completed
      • HTLV-I Infection
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 18, 2022

      Bacterial Growth, Novel Influenza A (H1N1) Trial in Jilin (A novel electrolyzed water spray reduces numbers of bacteria E-coli

      Recruiting
      • Bacterial Growth
      • Novel Influenza A (H1N1)
      • A novel electrolyzed water spray reduces numbers of bacteria E-coli and an attenuated human flu virus on human hands
      • Jilin, Changchun, China
        Changchun Jiahe Surgery Hospital
      Apr 1, 2023

      HIV-1, Human Immunodeficiency Virus 1, Immunodeficiency Virus Type 1, Human Trial (MK-8510)

      Not yet recruiting
      • HIV-1
      • +3 more
      • (no location specified)
      Jan 17, 2023

      HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))

      Enrolling by invitation
      • HIV
      • Antiretroviral Therapy Interruption(ATI)
      • Washington, District of Columbia
      • +1 more
      Sep 12, 2022

      Dengue Trial in Syracuse (Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC), Dengue virus 3 Live Virus Human Challenge

      Not yet recruiting
      • Dengue
      • Dengue virus 1 Live Virus Human Challenge (DENV-1-LVHC)
      • Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)
      • Syracuse, New York
        State University of New York, Upstate Medical University (SUNY-U
      Jul 28, 2023

      HTLV-I Infections Trial in Belém (Rehabilitation)

      Completed
      • HTLV-I Infections
      • Rehabilitation
      • Belém, Pará, Brazil
        Universidade da Amazônia
      Aug 11, 2020

      Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Classical Hodgkin Lymphoma Trial in Houston (CD30.CAR-EBVST cells)

      Recruiting
      • Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
      • Classical Hodgkin Lymphoma
      • CD30.CAR-EBVST cells
      • Houston, Texas
      • +1 more
      Jul 20, 2022

      EBV-positive Nasopharyngeal Carcinoma Trial in Guangzhou (Cohort A: 3.0x10^6 CAR-T cells/kg, Cohort B: 9.0x10^6CAR-T cells/kg,

      Not yet recruiting
      • EBV-positive Nasopharyngeal Carcinoma
      • Cohort A: 3.0x10^6 CAR-T cells/kg
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      May 16, 2023

      Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

      Recruiting
      • Hodgkin Disease
      • +5 more
      • MABEL CTLs
      • +2 more
      • Houston, Texas
      • +1 more
      Jan 13, 2023

      HIV-1-infection Trial in Madrid (BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato)

      Completed
      • HIV-1-infection
      • BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato
      • Madrid, Spain
        Hospital FUNDACIÓN JIMÉNEZ DÍAZ
      Nov 2, 2022

      Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

      Completed
      Has Results
      • Adult T-Cell Lymphoma/Leukemia
      • +2 more
      • Recombinant human Interleukin-15 (rhIL-15)
      • Mogamulizumab
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 9, 2022

      Influenza Virus - A Multicenter Registry

      Completed
      • Influenza Infection in Transplant Patients
        • Edmonton, Alberta, Canada
        • +1 more
        May 26, 2022

        Respiratory Syncytial Virus Trial in London (Molnupiravir, Placebo, RSV A Memphis 37b)

        Recruiting
        • Respiratory Syncytial Virus
        • London, London, City Of, United Kingdom
          hVIVO Services ( Site 0001)
        Feb 2, 2023

        Respiratory Syncytial Virus Infections, Influenza, Human Trial in London (RSV A Memphis 37, Influenza A/California/04/2009)

        Terminated
        • Respiratory Syncytial Virus Infections
        • Influenza, Human
        • RSV A Memphis 37
        • Influenza A/California/04/2009
        • London, United Kingdom
          National Heart and Lung Institute, Imperial College London
        Jun 23, 2022

        HIV Trial (Fostemsavir)

        Available
        • HIV Infections
        • (no location specified)
        Jun 13, 2022

        Human Immunodeficiency Virus, HIV Trial (Islatravir, Placebo)

        Not yet recruiting
        • Human Immunodeficiency Virus
        • HIV
        • (no location specified)
        Oct 13, 2022

        Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

        Not yet recruiting
        • Oropharyngeal Cancer
        • +10 more
        • (no location specified)
        Dec 14, 2022

        Rabies Virus Infection Trial in Kunming (Natural full human mAb CBB 1 injection, Rabies Human Immunoglobulin (HRIG), Natural

        Not yet recruiting
        • Rabies Virus Infection
        • Natural full human monoclonal antibody CBB 1 injection
        • +3 more
        • Kunming, Yunnan, China
          The First Affiliated Hospital of Yunnan University of Traditiona
        Apr 14, 2023

        Human Immunodeficiency Virus (HIV) Trial (Doravirine, Tenofovir, Lamivudine, ATRIPLA™, Placebo)

        Active, not recruiting
        Has Results
        • Human Immunodeficiency Virus (HIV)
        • Doravirine, Tenofovir, Lamivudine
        • +2 more
        • (no location specified)
        Sep 1, 2022

        Human Immunodeficiency Virus I Infection, Immunodeficiency Virus Type 1, Human, Human Immunodeficiency Virus Type 1 Trial in New

        Not yet recruiting
        • Human Immunodeficiency Virus I Infection
        • +2 more
        • MGD020
        • MGD014
        • (no location specified)
        Jun 27, 2022

        Human Immunodeficiency Virus Type 1 Trial in Worldwide (Rilpivirine)

        Recruiting
        • Human Immunodeficiency Virus Type 1
        • Brescia, Italy
        • +13 more
        Jan 17, 2023

        Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

        Recruiting
        • Myelodysplastic Syndrome
        • +16 more
        • Computed Tomography
        • +6 more
        • Scottsdale, Arizona
        • +2 more
        Feb 3, 2022